ResMed Inc. (FRA:RME)

ResMed Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	5,398	5,146	4,685	4,223	3,578	3,197
Revenue Growth (YoY)	9.57%	9.84%	10.95%	18.02%	11.93%	8.11%
Cost of Revenue	2,080	2,059	1,997	1,837	1,514	1,307
Gross Profit	3,318	3,087	2,688	2,386	2,064	1,889
Selling, General & Admin	1,045	991.02	917.14	874	737.51	670.39
Research & Development	348.68	331.28	307.53	287.64	253.58	225.28
Amortization of Goodwill & Intangibles	78.99	77.39	79.48	72.42	70.73	76.21
Operating Expenses	1,473	1,400	1,304	1,234	1,062	971.88
Operating Income	1,845	1,687	1,384	1,152	1,002	917.55
Interest Expense	-	-0.59	-49.72	-51.13	-22.31	-23.63
Interest & Investment Income	16.65	-	-	-	-	-
Earnings From Equity Investments	4.61	3.64	-1.85	-7.27	-8.49	-11.21
Currency Exchange Gain (Loss)	-7.61	-2.39	-0.14	-0.45	2.81	-0.75
Other Non Operating Income (Expenses)	0.1	1.83	0.66	-1.51	0.39	1.05
EBT Excluding Unusual Items	1,859	1,690	1,333	1,092	974.55	883.02
Merger & Restructuring Charges	-23.78	-2.03	-64.23	-20.13	-1.86	-13.87
Gain (Loss) on Sale of Investments	-14.06	-10.3	-4.05	9.92	-12.2	14.52
Pretax Income	1,819	1,678	1,265	1,102	960.48	883.66
Income Tax Expense	332.81	276.84	243.85	204.11	181.05	409.16
Net Income	1,486	1,401	1,021	897.56	779.44	474.51
Net Income to Common	1,486	1,401	1,021	897.56	779.44	474.51
Net Income Growth	18.99%	37.20%	13.75%	15.15%	64.26%	-23.67%
Shares Outstanding (Basic)	146	147	147	147	146	145
Shares Outstanding (Diluted)	147	147	148	147	147	146
Shares Change (YoY)	-0.43%	-0.14%	0.06%	0.28%	0.40%	0.55%
EPS (Basic)	10.16	9.55	6.94	6.12	5.34	3.27
EPS (Diluted)	10.11	9.51	6.92	6.09	5.30	3.24
EPS Growth	19.37%	37.43%	13.63%	14.91%	63.58%	-24.12%
Free Cash Flow	1,792	1,662	1,302	573.63	216.31	634.01
Free Cash Flow Per Share	12.20	11.28	8.82	3.89	1.47	4.33
Dividend Per Share	2.260	2.120	1.920	1.760	1.680	1.590
Dividend Growth	11.88%	10.42%	9.09%	4.76%	5.66%	1.92%
Gross Margin	61.47%	59.99%	57.38%	56.50%	57.68%	59.10%
Operating Margin	34.19%	32.79%	29.54%	27.28%	28.01%	28.70%
Profit Margin	27.53%	27.22%	21.79%	21.25%	21.78%	14.84%
Free Cash Flow Margin	33.19%	32.29%	27.79%	13.58%	6.04%	19.83%
EBITDA	2,025	1,860	1,534	1,292	1,126	1,029
EBITDA Margin	37.51%	36.15%	32.73%	30.60%	31.47%	32.19%
D&A For EBITDA	179.49	173	149.42	140.1	124.06	111.43
EBIT	1,845	1,687	1,384	1,152	1,002	917.55
EBIT Margin	34.19%	32.79%	29.54%	27.28%	28.01%	28.70%
Effective Tax Rate	18.30%	16.50%	19.28%	18.53%	18.85%	46.30%
Revenue as Reported	5,398	5,146	4,685	4,223	3,578	3,197

Source: S&P Global Market Intelligence. Standard template. Financial Sources.